Rational medical therapy for stable angina pectoris

Area of Science:

• Cardiology
• Pharmacology

Background:

• Angina pectoris arises from an imbalance between myocardial oxygen demand and supply, often due to coronary artery disease.
• Recent years have seen significant progress in understanding angina pathophysiology and its medical management.

Purpose of the Study:

• To critically review major anti-anginal drug classes: nitrates, beta blockers, and calcium channel blockers.
• To provide clinical perspectives and guidelines for selecting appropriate anti-anginal therapy.

Main Methods:

• Review of current pharmacologic agents used in angina treatment.
• Analysis of drug mechanisms, efficacy, and clinical application.

Main Results:

• Nitrates are first-line, beta blockers are effective for effort angina, and calcium channel blockers are efficacious for all anginal syndromes.
• Each drug class targets different pathophysiologic mechanisms of angina.

Conclusions:

• Optimal utilization of nitrates, beta blockers, and calcium channel blockers, individually or in combination, improves outcomes for patients with ischemic heart disease.
• Guidelines are proposed for selecting therapy, including special considerations for co-existing conditions like hypertension and heart failure.